Show simple item record

dc.contributor.authorÜnverengil, Gökçen
dc.contributor.authorBauer, Peter
dc.contributor.authorAyaz, Akif
dc.contributor.authorCalvo, Maria
dc.contributor.authorYüksel, Zafer
dc.contributor.authorMarais, Anett
dc.contributor.authorBertoli-Avella, Aida M.
dc.contributor.authorBeetz, Christian
dc.contributor.authorAltunoglu, Umut
dc.contributor.authorAlhashem, Amal
dc.contributor.authorMohamed, Sarar
dc.contributor.authorAlghamdi, Abdulaziz
dc.contributor.authorWillems, Patrick
dc.contributor.authorTsoutsou, Eirini
dc.contributor.authorFryssira, Helena
dc.contributor.authorPons, Roser
dc.contributor.authorAlmarzooq, Reem
dc.contributor.authorKaratoprak, Elif Yüksel
dc.date.accessioned2023-02-21T09:18:18Z
dc.date.available2023-02-21T09:18:18Z
dc.date.issued2022
dc.identifier.citationMarais A., Bertoli-Avella A. M., Beetz C., Altunoglu U., Alhashem A., Mohamed S., Alghamdi A., Willems P., Tsoutsou E., Fryssira H., et al., "Further clinical and genetic evidence of ASC-1 complex dysfunction in congenital neuromuscular disease", European Journal of Medical Genetics, cilt.65, sa.8, 2022
dc.identifier.issn1769-7212
dc.identifier.othervv_1032021
dc.identifier.otherav_2be3b2ec-186b-4fd9-a58c-3d67e9c6fc9d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/187364
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85132335769&origin=inward
dc.identifier.urihttps://doi.org/10.1016/j.ejmg.2022.104537
dc.description.abstract© 2022 Elsevier Masson SASTranscriptional coregulators modulate the efficiency of transcription factors. Bi-allelic variants in TRIP4 and ASCC1, two genes that encode members of the tetrameric coregulator ASC-1, have recently been associated with congenital bone fractures, hypotonia, and muscular dystrophy in a total of 22 unrelated families. Upon exome sequencing and data repository mining, we identified six new patients with pathogenic homozygous variants in either TRIP4 (n = 4, two novel variants) or ASCC1 (n = 2, one novel variant). The associated clinical findings confirm and extend previous descriptions. Considering all patients reported to date, we provide supporting evidence suggesting that ASCC1-related disease has a more severe phenotype compared to TRIP4-related disorder regarding higher incidence of perinatal bone fractures and shorter survival.
dc.language.isoeng
dc.subjectGenetik
dc.subjectGenetik (klinik)
dc.subjectTıbbi Genetik
dc.subjectYaşam Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTemel Bilimler
dc.subjectTıp
dc.subjectGENETİK VE KALITIM
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectDahili Tıp Bilimleri
dc.titleFurther clinical and genetic evidence of ASC-1 complex dysfunction in congenital neuromuscular disease
dc.typeMakale
dc.relation.journalEuropean Journal of Medical Genetics
dc.contributor.departmentCentogene AG , ,
dc.identifier.volume65
dc.identifier.issue8
dc.contributor.firstauthorID4128032


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record